Gemovac-OM: India's Indigenous Omicron-Specific mRNA Booster Vaccine Takes Center Stage in COVID-19 Vaccination Efforts
Gemovac-OM, India's Groundbreaking mRNA Vaccine, Raises Hope in COVID-19 Vaccination Efforts India has achieved a significant milestone in the fight against COVID-19 with the official launch of Gemovac-OM, an Omicron-specific mRNA-based booster vaccine. Developed by Gennova using indigenous platform technology, Gemovac-OM has received Emergency Use Authorization (EUA) from the Drug Control General of India (DCGI). This marks a major breakthrough as the first mRNA vaccine developed in India, contributing to the country's goal of self-reliance in vaccine production. Union Minister Jitendra Singh unveils Gemovac-OM, India's groundbreaking mRNA vaccine developed by Gennova, marking a significant milestone in the country's fight against COVID-19. Indigenous Technological Advancement Gemovac-OM is the result of the innovative indigenous platform technology developed by Gennova, with support from the Department of Biotechnology (DBT) and the Biotechnology Industry Research As...